In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS

Filed: July 1, 2020

* * * * * * * * * * * * * *

AMANDA JO KILGUS, * No. 18-513V

*

Petitioner, * Special Master Sanders

*

v. *

*

SECRETARY OF HEALTH * Dismissal; Insufficient Proof; 

AND HUMAN SERVICES, * Tetanus and Diptheria (“Td”) Vaccine;

* Anaphylaxis; Brachial Neuritis.

Respondent. *

* * * * * * * * * * * * * *

Nathan P. Powell, Webb, Tanner & Powell, P.C., Lawrenceville, GA, for Petitioner

Traci R. Patton, U.S. Department of Justice, Washington, DC, for Respondent

DISMISSAL1

On April 9, 2018, Amanda Kilgus (“Petitioner”) filed a petition for compensation under the 

National Vaccine Injury Compensation Program2 (“Vaccine Program” or “Program”). 42 U.S.C. § 

300aa-10 to 34 (2012). Petitioner alleges that she suffered “injuries, including anaphylaxis or 

anaphylactic shock and brachial neuritis,” as a result of a tetanus and diphtheria (“Td”) vaccine that she 

received on September 10, 2016. Pet. at 1, ECF No. 1. The information in the record, however, does 

not show entitlement to an award under the Program.

On September 25, 2019, Petitioner filed an unopposed motion for a decision dismissing her 

petition. ECF No. 29. In her motion, Petitioner conceded that “[a]n investigation of the facts and 

science supporting her case has demonstrated to petitioner that she will be unable to prove that she is 

entitled to compensation in the Vaccine Program.” Id. at 1. She continued, “to proceed further would 

be unreasonable and would not provide an efficient use of the resources of the Court, the [R]espondent 

and the Vaccine Program.” Id. Respondent had no objection to Petitioner’s motion. Id. at 1-2.

 1 This decision shall be posted on the United States Court of Federal Claims’ website, in accordance with 

the E-Government Act of 2002, 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic 

Government Services). This means the Decision will be available to anyone with access to the Internet. In 

accordance with Vaccine Rule 18(b), a party has 14 days to identify and move to delete medical or other 

information that satisfies the criteria in § 300aa-12(d)(4)(B). Further, consistent with the rule requirement, a 

motion for redaction must include a proposed redacted decision. If, upon review, the I agree that the identified 

material fits within the requirements of that provision, such material will be deleted from public access. 

2 National Childhood Vaccine Injury Act of 1986, Pub L. No. 99-660, 100 Stat. 3755 (“the Vaccine Act” 

or “Act”). Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent 

subparagraph of 42 U.S.C. § 300aa (2012). 
2

To receive compensation under the Program, Petitioner must prove either (1) that she suffered a 

“Table Injury”—i.e., an injury falling within the Vaccine Injury Table—corresponding to the 

vaccination, or (2) that she suffered an injury that was caused by a vaccine. See §§ 13(a)(1)(A), 

11(c)(1). An examination of the record did not uncover any evidence that Petitioner suffered a “Table 

Injury.” Further, the record does not contain persuasive evidence that Petitioner’s alleged injury was 

caused by the flu vaccine.

Under the Act, petitioners may not be given a Program award based solely on their claims alone. 

Rather, the petition must be supported by medical records or the opinion of a competent physician. § 

13(a)(1). In this case, the medical records are insufficient to prove Petitioner’s claim, and Petitioner has 

not filed a supportive opinion from an expert witness. Therefore, this case must be dismissed for 

insufficient proof. The Clerk shall enter judgment accordingly.

3

IT IS SO ORDERED. 

s/Herbrina D. Sanders 

Herbrina D. Sanders 

Special Master

 3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of a notice 

renouncing the right to seek review.